Navigation Links
Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference
Date:8/30/2012

UNION CITY, Calif., Aug. 30, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer , will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 11, 2012 at 4:30 p.m. ET. The conference will be held at the Grand Hyatt New York in New York City.

About Abaxis
Abaxis develops, manufactures, markets and sells portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.  The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients.  The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples.  The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.  The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a specialty instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid point-of-care tests for Heartworm infections, Parvovirus, Giardia and Lyme disease.  Abaxis, through its AVRL division, provides routine laboratory testing as well as specialty testing for veterinarians nationwide.Contact:

Clint Severson

Lytham Partners, LLCChief Executive Officer

Joe Dorame, Joe Diaz & Robert BlumABAXIS, Inc.

602-889-9700510-675-6500
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Abaxis, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
2. Abaxis, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
3. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
4. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
7. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
9. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
10. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
11. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 Intarcia ... interim clinical data for its lead candidate ITCA 650 ... patients with high baseline HbA1c levels at the 50 ... the Study of Diabetes (EASD). Data from the open-label, ... levels of blood sugar in patients with poorly controlled ...
(Date:9/19/2014)... , September 19, 2014 Reductions ... for many years in people with diabetes type 2 ... long term benefits for the kidneys." Australian ... with type 2 diabetes leads to persistent reductions in ... The global study has found that, five ...
(Date:9/18/2014)... Texas , Sept. 18, 2014  Low ... FDA committee meeting in Hyattsville, Maryland ... meeting to assess the proper patient population for ... potential cardiovascular risk associated with TRT. Examining recent claims ... committee found that "available epidemiological studies do not ...
Breaking Medicine Technology:Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2
... Africa, Dec. 23, 2011 Leatt Corporation (OTC: ... a neck brace system designed to help prevent potentially devastating ... announced that it held and webcast its 2011 Annual Meeting ... was present in person or by proxy. With ...
... 23, 2011 - Stupendous success on becoming Leader ... - Company,s main focus on ,Innovation & Creativity, ... Christmas present for Mr. Veeral Desai, Managing Director, Span Diagnostics ... nation,s most coveted ,ET NOW-IndiaMART Leaders of Tomorrow Awards 2011, ...
Cached Medicine Technology:Leatt Holds 2011 Annual Meeting of Shareholders 2Span Diagnostics Ltd. Hits Bull's eye at 'ET NOW-IndiaMART Leaders of Tomorrow Awards 2011' 2Span Diagnostics Ltd. Hits Bull's eye at 'ET NOW-IndiaMART Leaders of Tomorrow Awards 2011' 3
(Date:9/21/2014)... 21, 2014 “Cluster headaches are sometimes ... and difficult to resolve,” said Steve Young of Ew ... of a pain that is more intense.” , “It ... cluster headaches, or migraines, that medical research is pointing ... system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) is a ...
(Date:9/21/2014)... California (PRWEB) September 21, 2014 According to ... experienced the highest birth rate since 1966 (10.5 births per ... in their early 40s has risen steadily by 2 percent ... includes births to women aged 50 and over) also rose, ... that there were more than nine times as many first ...
(Date:9/20/2014)... 2014 Weight Destroyer , a ... expert Michael Wren that has already helped tens of ... health conditions like high blood pressure, high cholesterol, and ... prompting an investigative review. , “Weight Destroyer is ... down by showing people what is truly effective when ...
(Date:9/20/2014)... (PRWEB) September 21, 2014 Increases ... contributing to greater waste treatment volumes. However, government ... diverting waste from landfill. According to IBISWorld industry ... have implemented strategies aimed at reducing the volume ... waste recycled and recovered.” Still, a large proportion ...
(Date:9/20/2014)... The print component of “Work-Life ... the Calgary Herald, with a circulation of approximately ... The digital component is distributed nationally through a ... of top news sites and partner outlets. To ... http://www.worklifebalanceinfo.ca . , The publication features an ...
Breaking Medicine News(10 mins):Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 3Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 4Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2
... United American,Healthcare Corporation has nominated Bruce R. Galloway for ... Meeting of Shareholders scheduled,for Friday, November 7, 2008., ... shares of United,American Healthcare,s common stock, Lloyd I. Miller ... The proposal for the election of directors,is more fully ...
... 4 The National Patient Safety Foundation,(NPSF) today ... forum for leading health care solutions providers to ... and,patients and their families -- all with the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080307/AQF053LOGO ), "We are excited ...
... the University of Pennsylvania School of Medicine can now ... mature B-cells in the blood stream at any one ... germs to fight infections. , "There is a steady ... for humans," says senior author Michael P. Cancro, PhD, ...
... arthritis now have many more treatment options than in ... drugs, derived by modifying substances found in humans or ... treating the symptoms. The cost of biologic DMARDs is ... cost 100 times more than a year,s supply of ...
... Pycnodysostosis, a condition from which the painter Henri de ... stature. This rare disease, surprisingly, provides a window into ... by deficiency of an enzyme known as cathepsin K ... in bone modeling and repair), leading to poor bone ...
... HOUSTON, Nov. 4 US Oncology today announced ... has,exceeded the $10 million mark in assisting more than ... Advantage in August 2006., "It was important when ... access to oral chemotherapies by easing the financial,burdens these ...
Cached Medicine News:Health News:AmerisourceBergen Joins National Patient Safety Foundation Corporate Council 2Health News:Penn scientists show how body determines optimal amount of germ-fighting B cells 2Health News:Medicaid policies vary widely for rheumatoid arthritis drugs 2Health News:Genetic disorder sheds light on enzyme's role in bone metabolism 2Health News:OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $10 Million Milestone in Patient Financial Assistance 2Health News:OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $10 Million Milestone in Patient Financial Assistance 3
... Infinity™ ALT single liquid stable reagent ... quantitative determination of ALT in serum. ... not only provides excellent stability and ... correlation against existing assays. The reagent ...
... The Konelab 20XT analyzer is the ... clinical chemistry analyzers and reagents, designed to ... routine and specialty clinical laboratories. The Konelab ... as Konelab 20 and yet improves on ...
... works hand in hand with the Sequenza ... method for immunostaining. The Sequenza Immunostaining center ... consistency and excellent staining quality. Allows the ... to 50 slides/run) with a low chance ...
ISI Micro Brushes are available in a variety of French diameters. Made with stainless steel handles and nylon bristles, the ISI Micro Brushes will last through countless cleanings....
Medicine Products: